Cargando…
The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, China
In 2019, the Chinese government implemented the first round of the National Centralized Drug Procurement (NCDP) pilot (so-called “4 + 7” policy) in mainland China, in which 25 drugs were included. We conducted this study to examine the impacts of NCDP policy on drug utilization and expenditures, and...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765443/ https://www.ncbi.nlm.nih.gov/pubmed/33334027 http://dx.doi.org/10.3390/ijerph17249415 |
_version_ | 1783628491567136768 |
---|---|
author | Chen, Lei Yang, Ying Luo, Mi Hu, Borui Yin, Shicheng Mao, Zongfu |
author_facet | Chen, Lei Yang, Ying Luo, Mi Hu, Borui Yin, Shicheng Mao, Zongfu |
author_sort | Chen, Lei |
collection | PubMed |
description | In 2019, the Chinese government implemented the first round of the National Centralized Drug Procurement (NCDP) pilot (so-called “4 + 7” policy) in mainland China, in which 25 drugs were included. We conducted this study to examine the impacts of NCDP policy on drug utilization and expenditures, and to clarify the main factors contributing to drug expenditure changes. This study used drug purchasing order data from the Centralized Drug Procurement Survey in Shenzhen 2019. Drugs related to the “4 + 7” policy were selected as study samples, including 23 “4 + 7” policy-related varieties and 15 basic alternative drugs. Driving factors for drug expenditures changes were analyzed using A.M. index system analysis (Addis A. & Magrini N.’ method). After the implementation of the NCDP policy, the volume of “4 + 7” policy-related varieties increased by 73.8%, among which winning products jumped by 1638.2% and non-winning products dropped by 70.8%; the expenditures of “4 + 7” policy-related varieties decreased by 36.9%. Structure effects (0.47) and price effects (0.78) negatively contributed to the increase in drug expenditures of “4 + 7” policy-related varieties, while volume effects (1.73) had positive influence. NCDP policy successfully decreased drug expenditures of “4 + 7” policy-related varieties with structure effects playing a leading role. However, total drug expenditures were not effectively controlled due to the increasing use of alternative drugs. |
format | Online Article Text |
id | pubmed-7765443 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-77654432020-12-27 The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, China Chen, Lei Yang, Ying Luo, Mi Hu, Borui Yin, Shicheng Mao, Zongfu Int J Environ Res Public Health Article In 2019, the Chinese government implemented the first round of the National Centralized Drug Procurement (NCDP) pilot (so-called “4 + 7” policy) in mainland China, in which 25 drugs were included. We conducted this study to examine the impacts of NCDP policy on drug utilization and expenditures, and to clarify the main factors contributing to drug expenditure changes. This study used drug purchasing order data from the Centralized Drug Procurement Survey in Shenzhen 2019. Drugs related to the “4 + 7” policy were selected as study samples, including 23 “4 + 7” policy-related varieties and 15 basic alternative drugs. Driving factors for drug expenditures changes were analyzed using A.M. index system analysis (Addis A. & Magrini N.’ method). After the implementation of the NCDP policy, the volume of “4 + 7” policy-related varieties increased by 73.8%, among which winning products jumped by 1638.2% and non-winning products dropped by 70.8%; the expenditures of “4 + 7” policy-related varieties decreased by 36.9%. Structure effects (0.47) and price effects (0.78) negatively contributed to the increase in drug expenditures of “4 + 7” policy-related varieties, while volume effects (1.73) had positive influence. NCDP policy successfully decreased drug expenditures of “4 + 7” policy-related varieties with structure effects playing a leading role. However, total drug expenditures were not effectively controlled due to the increasing use of alternative drugs. MDPI 2020-12-15 2020-12 /pmc/articles/PMC7765443/ /pubmed/33334027 http://dx.doi.org/10.3390/ijerph17249415 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Chen, Lei Yang, Ying Luo, Mi Hu, Borui Yin, Shicheng Mao, Zongfu The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, China |
title | The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, China |
title_full | The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, China |
title_fullStr | The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, China |
title_full_unstemmed | The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, China |
title_short | The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, China |
title_sort | impacts of national centralized drug procurement policy on drug utilization and drug expenditures: the case of shenzhen, china |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765443/ https://www.ncbi.nlm.nih.gov/pubmed/33334027 http://dx.doi.org/10.3390/ijerph17249415 |
work_keys_str_mv | AT chenlei theimpactsofnationalcentralizeddrugprocurementpolicyondrugutilizationanddrugexpendituresthecaseofshenzhenchina AT yangying theimpactsofnationalcentralizeddrugprocurementpolicyondrugutilizationanddrugexpendituresthecaseofshenzhenchina AT luomi theimpactsofnationalcentralizeddrugprocurementpolicyondrugutilizationanddrugexpendituresthecaseofshenzhenchina AT huborui theimpactsofnationalcentralizeddrugprocurementpolicyondrugutilizationanddrugexpendituresthecaseofshenzhenchina AT yinshicheng theimpactsofnationalcentralizeddrugprocurementpolicyondrugutilizationanddrugexpendituresthecaseofshenzhenchina AT maozongfu theimpactsofnationalcentralizeddrugprocurementpolicyondrugutilizationanddrugexpendituresthecaseofshenzhenchina AT chenlei impactsofnationalcentralizeddrugprocurementpolicyondrugutilizationanddrugexpendituresthecaseofshenzhenchina AT yangying impactsofnationalcentralizeddrugprocurementpolicyondrugutilizationanddrugexpendituresthecaseofshenzhenchina AT luomi impactsofnationalcentralizeddrugprocurementpolicyondrugutilizationanddrugexpendituresthecaseofshenzhenchina AT huborui impactsofnationalcentralizeddrugprocurementpolicyondrugutilizationanddrugexpendituresthecaseofshenzhenchina AT yinshicheng impactsofnationalcentralizeddrugprocurementpolicyondrugutilizationanddrugexpendituresthecaseofshenzhenchina AT maozongfu impactsofnationalcentralizeddrugprocurementpolicyondrugutilizationanddrugexpendituresthecaseofshenzhenchina |